Bringing Safer, More Effective Drugs to Market
Leaders in the medical innovation field have outlined how government, nonprofit organizations and academic institutions can define new models of working with the private sector to enhance drug development efforts and bring safer, more effective drugs to the market more efficiently. The New Role of Academia in Drug Discovery and Development: New Thinking, New Competencies, New Results reflects key recommendations from a July 2010 town hall meeting in Kansas City hosted by Friends of Cancer Research, Kansas Bioscience Authority, The University of Kansas Cancer Center, Ewing Marion Kauffman Foundation and Council for American Medical Innovation.
Among the recommendations:
- University science leaders must identify areas in which external expertise is needed from nonprofits, industry, and government, and establish a focus on entrepreneurship.
- Federal agencies that fund translational research programs also should provide or require education about commercialization, including opportunities, challenges, and regulatory mandates.
- Universities should develop translational research training programs so current students, who will be future scientists, will be trained in next-generation techniques, applications, project management, collaboration models, and regulatory science.
- The National Institutes of Health (NIH) should invest in additional clinical and translational science awards (CTSAs) across the country and fund CTSA centers that bring unique capabilities and translational research and academic commercialization contributions to the consortium.
- Universities, in collaboration with industry, should establish models for intellectual property (IP) and technology transfer processes that will become widely adapted and trusted, removing many of today's hurdles to licensing and other opportunities to commercialize early innovation to translational outcomes.
Read the full report for additional recommendations and further explanation.
“We hope our nation’s healthcare leaders and policymakers will study the insights and adopt the recommendations in this report. We can make groundbreaking progress in how scientific discoveries translate to patient healthcare if they do,” said Lesa Mitchell, vice president of advancing innovations at the Kauffman Foundation.